Bir eğitim ve araştırma hastanesinde artan sıklıkta izole edilen Corynebacterium striatum izolatlarının değerlendirilmesi

Yıl 2015, Cilt: 72 Sayı: 4, 281 - 288, 01.12.2015

İpek Mumcuoğlu Gülşen Hazırolan Şenol Kurşun Neriman Aksu

Öz

Amaç: Corynebacterium striatum izolatları insan deri ve mukoz membranlarının normal flora üyesidirler ve çevrede yaygın olarak bulunurlar. Uzun yıllar mikrobiyolojik kültürlerde ürediklerinde kontaminant olarak kabul edilmişlerdir. Son yıllarda immünsupresif hasta sayısının, uygulanan invaziv işlemlerin ve geniş spektrumlu antibiyotik kullanımının artması, C. striatum izolatlarına bağlı enfeksiyon ve salgınların sayısında artışa neden olmuştur. Bu çalışmada hastanemizde son beş yıldır mikrobiyolojik kriterlere göre etken olarak kabul edilen C. striatum izolatları ve antibiyotik duyarlılıkları değerlendirilmiş ve izolasyon sıklığı hızla artan bu fırsatçı patojene dikkat çekilmeye çalışılmıştır. Yöntemler: Hastanemiz Tıbbi Mikrobiyoloji Laboratuvarına gönderilen çeşitli klinik örneklerin Gram boyalı preparatları hazırlanmış ve uygun besiyerlerine ekimleri yapılmıştır. Gram boyamada lökosit ve/ veya bakteri izlenen, kültürde baskın ya da saf üreme gösteren, tekrarlayan kültürlerde üreyen izolatlar etken olarak kabul edilmiş bu kriterleri karşılamayan üremeler kontaminasyon ya da kolonizasyon olarak raporlanmıştır. Tür düzeyinde identifikasyon 2010-2013 yılları arasında Vitek 2 bioMerieux, France ; 2014 yılında Bruker Microflex MS Bruker Daltonics, Bremen, Germany sistemleri ile yapılmıştır. Bulgular: Mikrobiyolojik kriterlere göre etken olarak kabul edilip raporlanan C. striatum izolatlarının sayısı 2010-2014 yılları arasında sırasıyla 52, 73, 191, 199, 231 toplam 746 bildirilmiştir. Bu izolatlardan 369 %49,5 ’u yara, 149 %20,0 ’u trakeal aspirat, 140 %18,8 ’ı kan, 38 %5,1 ’i steril vücut sıvısı, 31 %4,2 ’i idrar, 19 %2,5 ’u abse örneklerinden izole edilmiştir. En sık izolasyon YBÜ’lerinden %37,9 yapılmıştır. Antibiyotik duyarlılık testi sonuçlarına göre tüm etkenlerin çoklu dirençli oldukları izlenmiştir. 2010-2013 yılları arasında CLSI rehberine göre yapılan değerlendirmede siprofloksasin direnci %83,0, penisilin direnci %80,0, rifampicin direnci %79,1, klindamisin direnci %73,2, tetrasiklin direnci %69,9, eritromisin direnci %41,2 ve gentamisin direnci %17,6 bulunurken tüm suşların vankomisin ve linezolide duyarlı olduğu izlenmiştir. 2014 yılında EUCAST rehberine göre yapılan değerlendirmede ise tüm suşların sadece vankomisin ve linezolide duyarlı iken diğer tüm antibiyotiklere dirençli oldukları izlenmiştir. Sonuç: C. striatum izolatları klinik mikrobiyoloji laboratuvarında gittikçe daha sık karşılaştığımız bir patojen halini almaktadır. Özellikle immünsupresif ve/veya uzun süreli geniş spektrumlu antibiyotik tedavisi alan hastalarda, tanıda atlanılması, ölümcül sonuçlara yol açabilir. Bu çalışma ile hastanemizde artan sıklıkta karşılaştığımız bu çoklu dirençli etkene dikkat çekilmeye çalışılmıştır. Özellikle riskli hasta gruplarında mikrobiyolojik kriterlere göre enfeksiyon etkeni olabileceği düşünülen Corynebacterium izolatları mutlaka tür düzeyinde tanımlanmalı, duyarlılık testleri yapılmalı ve gerekli tedavi düzenlenmelidir

Anahtar Kelimeler

Corynebacterium striatum, çoklu ilaç direnci, enfeksiyon etkeni, kontaminasyon, kolonizasyon

Evaluation of the Corynebacterium striatum isolated with increasing frequency in one of the training and research hospital

Öz

Objective: Corynebacterium striatum strains are members of the normal flora of skin and mucous membranes, and commonly found in the environment. They have been regarded as contaminant for a long time when they reproduce in microbiological cultures. Lately, increase in the number of immunosuppressive patients and invasive procedures, and more frequent use of wide-spectrum antibiotics caused an increase in the number of reported infections and epidemics related to C. striatum strains. In this study, C. striatum isolates which are regarded as the infectious agents according to the microbiological criteria and their susceptibility to antibiotics were evaluated in our hospital for the last five years period and it was tried to attract the attention to this opportunistic pathogen having rapidly increasing isolation frequency. Methods: Various clinical samples sent to our hospital’s Medical Microbiology Laboratory were Gram stained, and cultured in appropriate agars. The strains with leucocytes and/or bacteria on Gram stain, dominant or absolute growth in culture, and growth in the repeated cultures were regarded as infectious agents while bacterial growths not fulfilling those criteria were reported as contamination or colonization. Identification of the agents at stain level was performed with Vitek 2 bioMerieux, France system between 2010 and 2013, and with Bruker Microflex MS Bruker Daltonics, Bremen, Germany system in 2014.Results: The numbers of C. striatum strains that were regarded and reported as infectious agents according to microbiological criteria between 2010 and 2014 were 52, 73, 191, 199, and 231, respectively total 746 . Among those, 369 49.5% strains were isolated from wounds, 149 20.0% from tracheal aspirates, 140 18.8% from blood, 38 5.1% from sterile body fluids, 31 4.2% from urine, and 19 2.5% from abscesses. The agents were most frequently isolated from ICU patients 37.9% . According to the antibiotic susceptibility test results it was observed that all agents were multiresistant. In the evaluation performed according to CLSI guidelines between the years 2010 and 2013 the ciprofloxacin, penicillin, rifampicin, clindamycin, tetracycline, and gentamycin resistance were found as 83.0%, 80.0%, 79.1%, 73.2%, 69.9%, 41.2%, 17.6% respectively and also it was observed that all the strains were susceptible to vancomycin and linezolid. In the evaluation performed according to EUCAST guideline in 2014 it was observed that all strains were susceptible only to vancomycin and linezolid, and resistant to all other antimicrobials. Conclusion: C. striatum isolates are becoming more and more frequently seen pathogens in the clinical microbiology laboratory. Missing their diagnosis as pathogens particularly in immunosuppressive patients and/ or in the ones on long-term treatment with widespectrum antibiotics may result in mortality. In this study, we tried to draw attention to this opportunistic, multiresistant pathogen with an increasing isolation rate in our hospital. Corynebacterium strains that may act as infectious agents according to microbiological criteria particularly in risky patient groups must be identified at strain level, their antimicrobial susceptibility tests must be performed, and the patients must be treated accordingl.

Anahtar Kelimeler

Corynebacterium striatum, multidrug resistance, infectious agent, contamination, colonization

Kaynakça

• 1. Boltin D, Katzir M, Bugoslavsky V, Yalashvili I, Brosh-Nissimov T, Fried M, et al. Corynebacterium striatum a classic pathogen eluding diagnosis. Eur J Intern Med, 2009; 20(3): 49-52.
• 2. Bernard K. The genus corynebacterium and other medically relevant coryneform-like bacteria. J Clin Microbiol, 2012; 50(10): 3152-8.
• 3. Funke G, von Graevenitz A, Clarridge JE, Bernard KA. Clinical microbiology of coryneform bacteria. Clin Microbiol Rev, 1997;10(1): 125-59.
• 4. Renom F, Gomila M, Garau M, Gallegos MD, Guerrero D, Lalucat J, et al. Respiratory infection by Corynebacterium striatum: epidemiological and clinical determinants. New Microbes New Infect, 2014; 2(4): 106-14.
• 5. Verroken A, Bauraing C, Deplano A, Bogaerts P, Huang D, Wauters G, et al. Epidemiological investigation of a nosocomial outbreak of multidrug-resistant Corynebacterium striatum at one Belgian university hospital. Clin Microbiol Infect, 2014; 20(1): 44-50.
• 6. Baio PV, Mota HF, Freitas AD, Gomes DL, Ramos JN, SantAnna LO, et al. Clonal multidrug-resistant Corynebacterium striatum within a nosocomial environment, Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz, 2013; 108(1): 23-9.
• 7. Díez-Aguilar M, Ruiz-Garbajosa P, Fernández-Olmos A, Guisado P, Del Campo R, Quereda C, et al. Nondiphtheriae Corynebacterium species: an emerging respiratory pathogen. Eur J Clin Microbiol Infect Dis, 2013; 32(6): 769-72.
• 8. Wong KY, Chan YC, Wong CY. Corynebacterium striatum as an emerging pathogen. J Hosp Infect, 2010; 76(4): 371-2.
• 9. Campanile F, Carretto E, Barbarini D, Grigis A, Falcone M, Goglio A, et al. Clonal multidrugresistant Corynebacterium striatum strains, Italy. Emerg Infect Dis, 2009; 15(1): 75-8.
• 10. Renom F, Garau M, Rubí M, Ramis F, Galmés A, Soriano JB. Nosocomial outbreak of Corynebacterium striatum infection in patients with chronic obstructive pulmonary disease. J Clin Microbiol, 2007; 45(6): 2064-7.
• 11. Otsuka Y, Ohkusu K, Kawamura Y, Baba S, Ezaki T, Kimura S. Emergence of multidrug-resistant Corynebacterium striatum as a nosocomial pathogen in long-term hospitalized patients with underlying diseases. Diagn Microbiol Infect Dis, 2006; 54(2): 109-14.
• 12. Savini V, Gherardi G, Favaro M, Fontana C, Marrollo R, Argentieri AV, et al. About a bloodstream Corynebacterium striatum isolate. Folia Microbiol, 2013; 58(6): 451-3.
• 13. Tarr PE, Stock F, Cooke RH, Fedorko DP, Lucey DR. Multidrug-resistant Corynebacterium striatum pneumonia in a heart transplant recipient. Transpl Infect Dis, 2003; 5(1): 53-8.
• 14. Weiss K, Labbé AC, Laverdière M. Corynebacterium striatum meningitis: case report and review of an increasingly important Corynebacterium species. Clin Infect Dis, 1996; 23(6):1246-8.
• 15. Mizoguchi H, Sakaki M, Inoue K, Kobayashi Y, Iwata T, Suehiro Y, et al. Quadricuspid aortic valve complicated with infective endocarditis: report of a case. Surg Today, 2014; 44(12): 2388-91.
• 16. Fernández Guerrero ML, Robles I, Nogales Mdel C, Nuevo D. Corynebacterium striatum: an emerging nosocomial drug-resistant endocardial pathogen. J Heart Valve Dis, 2013; 22(3): 428-30.
• 17. Abi R, Ez-Zahraouii K, Ghazouani M, Zohoun A, Kheyi J, Chaib A, et al. A Corynebacterium striatum endocarditis on a carrier of pacemaker. Ann Biol Clin, 2012; 70(3): 329-31.
• 18. Batalla AS, de La Blanchardière A, Vergnaud M, Dargère S, Verdon R. Recurrent Corynebacterium striatum endocarditis, secondary to osteomyelitis. Med Mal Infect, 2011; 41(3): 160-3.
• 19. Fernández-Ayala M, Nan DN, Fariñas MC. Vertebral osteomyelitis due to Corynebacterium striatum. Am J Med, 2001; 111(2): 167.
• 20. Westblade LF, Shams F, Duong S, Tariq O, Bulbin A, Klirsfeld D, et al. Septic arthritis of a native knee joint due to Corynebacterium striatum. J Clin Microbiol, 2014; 52(5): 1786-8.
• 21. Fernández Guerrero ML, Robles I, Nogales Mdel C, Nuevo D. Corynebacterium striatum: an emerging nosocomial drug-resistant endocardial pathogen. J Heart Valve Dis, 2013; 22(3): 428-30.
• 22. Heidemann DG, Dunn SP, Diskin JA, Aiken TB. Corynebacterium striatum keratitis. Cornea, 1991; 10(1): 81-82.
• 23. Superti SV, Martins Dde S, Caierão J, Soares F, Prochnow T, Cantarelli VV, et al. Corynebacterium striatum infecting a malignant cutaneous lesion: the emergence of an opportunistic pathogen. Rev Inst Med Trop Sao Paulo, 2009; 51(2): 115-6.
• 24. Moore K, Hall V, Paul A, Morris T, Brown S, McCulloch D, et al. Surface bacteriology of venous leg ulcers and healing outcome. J Clin Pathol, 2010; 63(9): 830-4.
• 25. Beteta López A, Gil Ruiz MT, Vega Prado L, Fajardo Olivares M. Cystitis and haematuria due to Corynebacterium striatum. A case report and review. Actas Urol Esp, 2009; 33(8): 909-12.
• 26. Chen FL, Hsueh PR, Teng SO, Ou TY, Lee WS. Corynebacterium striatum bacteremia associated with central venous catheter infection. J Microbiol Immunol Infect, 2012; 45(3): 255-8.
• 27. Boltin D, Katzir M, Bugoslavsky V, Yalashvili I, Brosh-Nissimov T, Fried M, et al. Corynebacterium striatum - a classic pathogen eluding diagnosis. Eur J Intern Med, 2009; 20(3): 49-52.
• 28. Severo CB, Guazzelli LS, Barra MB, Hochhegger B, Severo LC. Multiple pulmonary nodules caused by Corynebacterium striatum in an immunocompetent patient. Rev Inst Med Trop Sao Paulo, 2014; 56(1): 89-91.
• 29. López AB, Gil Ruiz MT, Vega PL, Fajardo OM. Cystitis and haematuria due to Corynebacterium striatum. A case report and review. Actas Urol Esp, 2009; 33(8): 909-12.
• 30. Funke G, Bernard KA. Coryneform Gram-positive rods. In Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML,Warnock DW (ed), Manual of Clinical Microbiology, 10th Ed. ASM Press, Washington, DC, 2011:413–42.
• 31. Weinstein MP. Contaminated or not? Guidelines for interpretation of positive blood cultures. WebM&M. January 2008. Agency for Healthcar Research and Quality, Rockville, MD. http://webmm.ahrq.gov/ printviewcase.aspx?caseID_168.
• 32. Biswal I, Mohapatra S, Deb M, Dawar R, Gaind R. Corynebacterium striatum: an emerging nosocomial pathogen in a case of laryngeal carcinoma. Indian J Med Microbiol, 2014; 32(3): 323-4.
• 33. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Nineteenth-twenty second Informational Supplement. Document M100- S19-S22, 2009-2012 CLSI, Wayne, PA.
• 34. European Committee on Antimicrobial Susceptibility Testing [Internet]. [Accessed 1 Nov 2013]. Available from: http://www.eucast.org.
• 35. Brandenburg AH, van Belkum A, van Pelt C, Bruining HA, Mouton JW, Verbrugh HA. Patient-to-patient spread of a single strain of Corynebacterium striatum causing infections in a surgical intensive care unit. J Clin Microbiol, 1996; 34(9): 2089-94.
• 36. Leonard RB, Nowowiejski DJ, Warren JJ, Finn DJ, Coyle MB. Molecular evidence of person-toperson transmission of a pigmented strain of Corynebacterium striatum intensive care units. J Clin Microbiol, 1994; 32(1): 164-9.
• 37. Otsuka Y, Ohkusu K, Kawamura Y, Baba S, Ezaki T, Kimura S. Emergence of multidrug-resistant Corynebacterium striatum as a nosocomial pathogen in long-term hospitalized patients with underlying diseases. Diagn Microbiol Infect Dis, 2006; 54(2): 109-114.
• 38. Blaise G, Nikkels AF, Hermanns-Lê T, NikkelsTassoudji N, Piérard GE. Corynebacteriumassociated skin infections. Int J Dermatol, 2008; 47(9): 884-90